Kos Hires M&A Specialist

The appointment of former Bear Stearns managing director Kevin Clarke boosts the stock.
Author:
Publish date:

Kos Pharmaceuticals (KOSP) named Bear Stearns (BSC) M&A specialist Kevin P. Clarke chief financial officer.

The Cranbury, N.J., drug company said Clarke, 46, was a senior managing director responsible for healthcare mergers and acquisitions at New York-based Bear Stearns. He will be responsible for overseeing all of Kos' finance, accounting, business planning and investor relations functions.

"Kevin's leadership and strategic focus at Bear Stearns, together with his extensive experience in healthcare merger and acquisition transactions, capital and financial management make him an ideal choice for this important position," said CEO Adrian Adams. "He brings a deep knowledge and understanding of the healthcare and specialty pharmaceutical industry, its products and the fundamentals that drive the sector. He also brings significant Wall Street experience with strategic financial transactions and expertise in creating opportunities for shareholder value. Kevin has the disposition, integrity and knowledge that are fundamental to the Chief Financial Officer position. I have no doubt that he will make a huge contribution to Kos and I am looking forward to working with him in continuing our strong financial momentum in the short-, medium- and long-term."

The appointment comes just two weeks after Kos

hired a flack.

On Wednesday, Kos rose $1.69 to $60.45.